Abrocitinib interferes with the performance of T-SPOT.TB assay for latent tuberculosis reactivation: an in vitro study

J Am Acad Dermatol. 2025 Jan 21:S0190-9622(25)00103-3. doi: 10.1016/j.jaad.2025.01.026. Online ahead of print.

Authors

Yiting Li¹, Xi Tan¹, Shu Nie¹, Bin Chen¹, Chaoshuai Zhao¹, Ran Liu¹, Zhouwei Wu²

Affiliations

¹ Department of Dermatology, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
² Department of Dermatology, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China. Electronic address: zhouwei.wu@shgh.cn.

PMID: 39848585
DOI: 10.1016/j.jaad.2025.01.026

No abstract available

Keywords: T-SPOT.TB; abrocitinib; latent tuberculosis infection.